Remyelination capacity of the MS brain decreases with disease chronicity

T Goldschmidt1, J Antel, F B König

  • 1Department of Neuropathology, University Medical Center, Göttingen, Germany.

Neurology
|June 3, 2009
PubMed
Abstract

Insights

Remyelination is frequent in early multiple sclerosis (MS) lesions but less common in chronic MS. Lesion location also influences remyelination extent, with subcortical lesions showing more repair than periventricular ones.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system.
  • Remyelination, the process of restoring myelin sheaths around axons, is a key factor in recovery and neuroprotection in MS.
  • The extent and frequency of remyelination in early versus chronic MS lesions remain incompletely understood.

Purpose of the Study:

  • To quantitatively compare the extent of remyelination in early and chronic MS lesions.
  • To investigate the impact of lesion anatomic localization on remyelination in MS.
  • To provide a detailed analysis of remyelination patterns across different disease durations and locations.

Main Methods:

  • Immunohistochemical analysis of myelin proteins in biopsy samples from early MS lesions and autopsy cases of chronic MS lesions.
  • Quantification of remyelination occurrence and extent.
  • Correlation of remyelination with lesion location, patient sex, age, and disease duration.

Main Results:

  • A significantly higher proportion of early MS lesions (80.7%) showed remyelination compared to chronic MS lesions (60%).
  • In chronic MS, subcortical lesions exhibited more extensive remyelination than periventricular lesions.
  • Cerebellar lesions in chronic MS were predominantly completely demyelinated.

Conclusions:

  • Remyelination is a common occurrence in the early stages of multiple sclerosis.
  • The anatomical site of a demyelinating lesion influences the capacity for remyelination.
  • These findings highlight the dynamic nature of remyelination in MS and its dependence on disease stage and location.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...